PubRank

Angela Corpolongo

Author PubWeight™ 23.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 2007 4.30
2 Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother 2007 1.89
3 Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol 2005 1.87
4 Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retroviruses 2005 1.52
5 Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2006 1.41
6 Effective highly active antiretroviral therapy in patients with primary HIV-1 infection prevents the evolution of the avidity of HIV-1-specific antibodies. J Acquir Immune Defic Syndr 2007 1.01
7 Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection. AIDS 2011 0.98
8 The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis. BMC Infect Dis 2013 0.88
9 Left thigh phlegmon caused by Nocardia farcinica identified by 16S rRNA sequencing in a patient with leprosy: a case report. BMC Infect Dis 2013 0.84
10 Total hip replacement infected with Mycobacterium tuberculosis complicated by Addison disease and psoas muscle abscess: a case report. J Med Case Rep 2012 0.84
11 Cystic echinococcosis in a single tertiary care center in Rome, Italy. Biomed Res Int 2013 0.81
12 Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report. Clin Vaccine Immunol 2013 0.80
13 Managing patients with sexual transmission of drug-resistant HIV. Sex Health 2005 0.79
14 A case of pulmonary tuberculosis presenting as diffuse alveolar haemorrhage: is there a role for anticardiolipin antibodies? BMC Infect Dis 2010 0.78
15 HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy. AIDS 2012 0.78
16 CD8 T cell response to Nef peptides and HIV type 1 control in early-treated patients after antiretroviral treatment interruption. AIDS Res Hum Retroviruses 2006 0.78
17 Application of a molecular panel to demonstrate enterotropic virus shedding by healthy and human immunodeficiency virus-infected patients. J Clin Microbiol 2005 0.75
18 Tolerability of HAART in patients treated during acute HIV infection. J Acquir Immune Defic Syndr 2010 0.75
19 Stopping antiretroviral therapy: role for therapeutic drug monitoring. AIDS 2008 0.75
20 Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report. Infect Agent Cancer 2012 0.75